- Home
- NVNO vs NCSM Comparison
NVNO vs NCSM Comparison
Compare NVNO & NCSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- NCSM
- Stock Information
- Founded
- NVNO 1987
- NCSM 2006
- Country
- NVNO United States
- NCSM United States
- Employees
- NVNO N/A
- NCSM N/A
- Industry
- NVNO Medical/Dental Instruments
- NCSM Oilfield Services/Equipment
- Sector
- NVNO Health Care
- NCSM Energy
- Exchange
- NVNO Nasdaq
- NCSM Nasdaq
- Market Cap
- NVNO 59.4M
- NCSM 51.9M
- IPO Year
- NVNO N/A
- NCSM 2017
- Fundamental
- Price
- NVNO $3.30
- NCSM $23.73
- Analyst Decision
- NVNO
- NCSM
- Analyst Count
- NVNO 0
- NCSM 0
- Target Price
- NVNO N/A
- NCSM N/A
- AVG Volume (30 Days)
- NVNO 117.4K
- NCSM 5.4K
- Earning Date
- NVNO 10-31-2024
- NCSM 10-30-2024
- Dividend Yield
- NVNO N/A
- NCSM N/A
- EPS Growth
- NVNO N/A
- NCSM N/A
- EPS
- NVNO N/A
- NCSM 16.77
- Revenue
- NVNO N/A
- NCSM $152,801,000.00
- Revenue This Year
- NVNO N/A
- NCSM $13.26
- Revenue Next Year
- NVNO N/A
- NCSM $6.32
- P/E Ratio
- NVNO N/A
- NCSM $1.42
- Revenue Growth
- NVNO N/A
- NCSM 3.66
- 52 Week Low
- NVNO $3.01
- NCSM $12.16
- 52 Week High
- NVNO $6.97
- NCSM $24.95
- Technical
- Relative Strength Index (RSI)
- NVNO 43.55
- NCSM 69.32
- Support Level
- NVNO $3.24
- NCSM $22.21
- Resistance Level
- NVNO $3.75
- NCSM $24.75
- Average True Range (ATR)
- NVNO 0.18
- NCSM 0.86
- MACD
- NVNO 0.02
- NCSM 0.21
- Stochastic Oscillator
- NVNO 12.62
- NCSM 78.87
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc provides products and support services that facilitate the optimization of oil and natural gas well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's primary offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. Geographically, majority of revenue is generated from United States.